Unknown

Dataset Information

0

Regulation of amyloid precursor protein processing by serotonin signaling.


ABSTRACT: Proteolytic processing of the amyloid precursor protein (APP) by the ?- and ?-secretases releases the amyloid-? peptide (A?), which deposits in senile plaques and contributes to the etiology of Alzheimer's disease (AD). The ?-secretase cleaves APP in the A? peptide sequence to generate soluble APP? (sAPP?). Upregulation of ?-secretase activity through the 5-hydroxytryptamine 4 (5-HT4) receptor has been shown to reduce A? production, amyloid plaque load and to improve cognitive impairment in transgenic mouse models of AD. Consequently, activation of 5-HT4 receptors following agonist stimulation is considered to be a therapeutic strategy for AD treatment; however, the signaling cascade involved in 5-HT4 receptor-stimulated proteolysis of APP remains to be determined. Here we used chemical and siRNA inhibition to identify the proteins which mediate 5-HT4d receptor-stimulated ?-secretase activity in the SH-SY5Y human neuronal cell line. We show that G protein and Src dependent activation of phospholipase C are required for ?-secretase activity, while, unexpectedly, adenylyl cyclase and cAMP are not involved. Further elucidation of the signaling pathway indicates that inositol triphosphate phosphorylation and casein kinase 2 activation is also a prerequisite for ?-secretase activity. Our findings provide a novel route to explore the treatment of AD through 5-HT4 receptor-induced ?-secretase activation.

SUBMITTER: Pimenova AA 

PROVIDER: S-EPMC3897773 | biostudies-literature | 2014

REPOSITORIES: biostudies-literature

altmetric image

Publications

Regulation of amyloid precursor protein processing by serotonin signaling.

Pimenova Anna A AA   Thathiah Amantha A   De Strooper Bart B   Tesseur Ina I  

PloS one 20140121 1


Proteolytic processing of the amyloid precursor protein (APP) by the β- and γ-secretases releases the amyloid-β peptide (Aβ), which deposits in senile plaques and contributes to the etiology of Alzheimer's disease (AD). The α-secretase cleaves APP in the Aβ peptide sequence to generate soluble APPα (sAPPα). Upregulation of α-secretase activity through the 5-hydroxytryptamine 4 (5-HT4) receptor has been shown to reduce Aβ production, amyloid plaque load and to improve cognitive impairment in tran  ...[more]

Similar Datasets

| S-EPMC2886067 | biostudies-literature
| S-EPMC3805747 | biostudies-literature
| S-EPMC5361499 | biostudies-literature
| S-EPMC3931259 | biostudies-literature
| S-EPMC7206886 | biostudies-literature
| S-EPMC3585261 | biostudies-literature
| S-EPMC3309763 | biostudies-literature
| S-EPMC3029320 | biostudies-literature
| S-EPMC2823633 | biostudies-other
| S-EPMC3188680 | biostudies-literature